1. Home
  2. PESI vs ABOS Comparison

PESI vs ABOS Comparison

Compare PESI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$12.65

Market Cap

225.2M

Sector

Industrials

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.43

Market Cap

182.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
ABOS
Founded
1990
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.2M
182.0M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
PESI
ABOS
Price
$12.65
$2.43
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
99.6K
374.4K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
N/A
Revenue
$642,000.00
N/A
Revenue This Year
$34.62
N/A
Revenue Next Year
$77.02
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.14
$0.96
52 Week High
$16.50
$3.60

Technical Indicators

Market Signals
Indicator
PESI
ABOS
Relative Strength Index (RSI) 53.13 40.19
Support Level $12.40 $2.19
Resistance Level $14.80 $2.42
Average True Range (ATR) 0.55 0.13
MACD 0.06 -0.03
Stochastic Oscillator 57.55 9.85

Price Performance

Historical Comparison
PESI
ABOS

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: